FDA Using More Temporary Advisory Committee Members To Fill Vacancies
This article was originally published in The Tan Sheet
Executive Summary
FDA advisory committees are increasingly relying on temporary members to fill their ranks - a trend that could result in less predictability for drug sponsors at a make-or-break review meeting